EPISODE · Aug 7, 2018 · 32 MIN
Transplant & Veno-Occlusive Disease (VOD)
from The Bloodline with Blood Cancer United Podcast
Joseph Antin, MD Many may be familiar with graft versus host disease (GVHD) however, veno-occlusive disease (VOD), otherwise known as sinusoidal obstruction syndrome (SOS), is also one of the most frequently encountered complications after stem cell transplantation. Listen in as Alicia and Lizette from The Leukemia & Lymphoma Society (LLS) speak with Dr. Joseph Antin, Chief of the Stem Cell Transplant Program of the Department of Medical Oncology at Dana Farber Cancer Institute and Brigham and Women’s Hospital in Boston, Massachusetts. On this episode they will discuss the difference between a bone marrow and stem cell transplant, treating VOD, autologous and allogeneic transplants, how doctors choose the cell source collected from the blood or the marrow that is best for the patient, VOD as it presents in pediatric and adult patients and interesting findings about herbal tea induced hepatic veno-occlusive disease. CLICK HERE to participate in our episode survey. As mentioned on this episode: Veno-occlusive Disease (VOD) Stem Cell Transplants Autologous Stem Cell Transplantation Allogeneic Stem Cell Transplantation Graft Versus Host Disease (GVHD) Blood and Marrow Stem Cell Transplantation Booklet Cord Blood Stem Cell Transplantation Fact Sheet Additional LLS Support Resources: Information Specialists Free telephone/web patient programs Free booklets Financial support Online chats Caregiver support LLS Community Support groups Patti Robinson Kaufmann First Connection Program Please comment below as we’d love to hear your feedback on this episode. Also, be sure to subscribe today to be notified of our next episode. Support for this program provided by Jazz Pharmaceuticals.The post Transplant & Veno-Occlusive Disease (VOD) first appeared on The Bloodline with Blood Cancer United Podcast.
NOW PLAYING
Transplant & Veno-Occlusive Disease (VOD)
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m